Outbreak of Mycobacterium massiliense infection associated with intramuscular injections.
Twelve strains of a rapidly growing Mycobacterium species were isolated from an outbreak associated with intramuscular injections of an antimicrobial agent and were identified by comparative sequence analysis of rpoB and hsp65. These isolates were identified as Mycobacterium massiliense (100% similarity).
Kim
Hee-Youn
HY
Department of Microbiology, Cancer Research Institute, Institute of Endemic Diseases, SNUMRC, Korea.
Yun
Yeo-Jun
YJ
Park
Chan Geun
CG
Lee
Dong Han
DH
Cho
Yong Kyun
YK
Park
Byung Joo
BJ
Joo
Sae-Ick
SI
Kim
Eui-Chong
EC
Hur
Young Joo
YJ
Kim
Bum-Joon
BJ
Kook
Yoon-Hoh
YH
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001426:Bacterial Proteins / Q000235:genetics; D018834:Chaperonin 60; D018833:Chaperonins / Q000235:genetics; D002648:Child; D002675:Child, Preschool; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D012321:DNA-Directed RNA Polymerases / Q000235:genetics; D004196:Disease Outbreaks; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009161:Mycobacterium / Q000235:genetics / Q000302:isolation & purification*; D009164:Mycobacterium Infections / Q000453:epidemiology* / Q000382:microbiology*; D010802:Phylogeny; D012271:Ribostamycin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D017422:Sequence Analysis, DNA
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D018834:Chaperonin 60; D004269:DNA, Bacterial; C074119:heat-shock protein 65, Mycobacterium; D012271:Ribostamycin; D012321:DNA-Directed RNA Polymerases; C105078:RNA polymerase beta subunit; D018833:Chaperonins